英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
hoofs查看　hoofs　在百度字典中的解释百度英翻中〔查看〕
hoofs查看　hoofs　在Google字典中的解释Google英翻中〔查看〕
hoofs查看　hoofs　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Leishmaniasis - World Health Organization (WHO)
    Visceral leishmaniasis is the main form of the disease, which is also endemic for cutaneous leishmaniasis Post-kala-azar dermal leishmaniasis (PKDL) Post-kala-azar dermal leishmaniasis (PKDL) is usually a sequel of visceral leishmaniasis that appears as macular, papular or nodular rash usually on face, upper arms and trunk It occurs in east
  • Leishmaniasis - World Health Organization (WHO)
    Leishmaniasis is caused by the protozoan Leishmania parasites which are transmitted by the bite of infected female phlebotomine sandflies There are 3 main forms of leishmaniases – visceral (also known as kala-azar, which is and the most serious form of the disease), cutaneous (the most common), and mucocutaneous
  • Leishmaniasis - World Health Organization (WHO)
    Leishmaniasis cutánea: esta forma, que es la más frecuente, provoca lesiones cutáneas, sobre todo ulcerosas, en las zonas expuestas del cuerpo, que pueden dejar cicatrices de por vida y causar discapacidad grave o la estigmatización de la persona Alrededor del 95% de los casos se producen en las Américas, la cuenca del Mediterráneo, Oriente Medio y Asia Central Se calcula que cada año
  • Leishmaniasis - World Health Organization (WHO)
    There are three main types of leishmaniasis: i) visceral, often known as kala-azar and the most serious form of the disease (VL); ii) cutaneous, the most common (CL); and iii) mucocutaneous <o:p>< o:p> The disease mainly affects poor people in Africa, Asia and Latin America, and is associated with malnutrition, population displacement, poor housing, weak immune system and lack of resources
  • Leishmaniasis - World Health Organization (WHO)
    Leishmaniasis is a protozoan disease in which clinical manifestations depend on both the infecting species of Leishmania and the immune response of the host Transmission of the disease occurs by the bite of a sandfly infected with Leishmania parasites There are four main types of the disease
  • Leishmaniasis WPRO - World Health Organization (WHO)
    Leishmaniasis is linked to environmental changes such as deforestation, building of dams, irrigation schemes, and urbanization It affects some of the poorest people on earth, and is associated with malnutrition, population displacement, poor housing, a weak immune system, and lack of financial resources Leishmaniasis is a treatable and curable disease
  • Leishmaniasis | WHO | Regional Office for Africa
    Leishmaniasis is caused by a protozoa parasite from over 20 Leishmania species Over 90 sandfly species are known to transmit Leishmania parasites There are 3 main forms of the disease: Visceral leishmaniasis (VL), also known as kala-azar, is fatal if left untreated in over 95% of cases It is characterized by irregular bouts of fever, weight
  • WHO publishes two landmark documents on leishmaniasis
    Leishmaniasis is caused by a protozoan parasite from over 20 Leishmania species Over 90 sand fly species are known to transmit Leishmania parasites There are three main forms of the disease: Visceral leishmaniasis: 4 Fatal if left untreated, it is characterized by irregular bouts of fever, weight loss, enlargement of the spleen and liver and
  • African Nations unite to eliminate visceral leishmaniasis and boost . . .
    Eliminating visceral leishmaniasis in eastern Africa With this MoU, the ministers or their representatives of Chad, Djibouti, Ethiopia, Somalia, South Sudan and Sudan agreed to invest resources, develop effective policies and collaborate closely to achieve the ambitious targets outlined in the VL strategic framework launched in June 2024
  • Global leishmaniasis surveillance updates 2023: 3 years of the NTD road map
    The aims of this report are to update the description of the GHO leishmaniasis indicators reported by Member States to WHO up to 2023, to describe specific indicators of gender and age distribution, relapse, treatment for cutaneous leishmaniasis (CL), visceral leishmaniasis (VL) and VL treatment outcomes, VL case fatality rates (CFRs) and the burden of post kala-azar dermal leishmaniasis (PKDL





中文字典-英文字典  2005-2009